COMPARISON OF ACETYLATION OF PROCAINAMIDE AND SULFADIMIDINE IN MAN

被引：29

作者：

FRISLID, K

BERG, M

HANSTEEN, V

LUNDE, PKM

机构：

[1] ULLEVAL HOSP,CENT LAB,DIV CLIN PHARMACOL & TOXICOL,OSLO 1,NORWAY

[2] ULLEVAL HOSP,DEPT MED 8,OSLO,NORWAY

来源：

关键词：

D O I：

10.1007/BF00606561

中图分类号：

R9 [药学];

学科分类号：

1007 ;

摘要：

引用

页码：433 / 438

页数：6

共 18 条

[1] ATKINSON AJ, 1972, CLIN CHEM, V18, P643
[2] DRAYER DE, 1974, P SOC EXP BIOL MED, V146, P358
[3] DREYFUSS J, 1972, CLIN PHARMACOL THER, V13, P366
[4] ANTIARRHYTHMIC POTENCY OF N-ACETYLPROCAINAMIDE
ELSON, J
STRONG, JM
LEE, WK
ATKINSON, AJ
[J]. CLINICAL PHARMACOLOGY & THERAPEUTICS, 1975, 17 (02) : 134 - 140
[5] EVANS D A P, 1969, Journal of Medical Genetics, V6, P405, DOI 10.1136/jmg.6.4.405
[6] NEW SUSTAINED-RELEASE TABLET FORMULATION OF PROCAINAMIDE
FREMSTAD, D
DAHL, S
JACOBSEN, S
LUNDE, PKM
NADLAND, KJ
MARTHINSEN, AA
WAALER, T
LANDMARK, KH
[J]. EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 1973, 6 (04) : 251 - 255
[7] FRISLID K, 1975, CLIN CHEM, V21, P1180
[8] GIBSON TP, 1975, CLIN PHARMACOL THER, V17, P395
[9] GIBSON TP, 1975, CLIN PHARMACOL THER, V17, P321
[10] GRAFFNER C, 1975, CLIN PHARMACOL THER, V17, P414